These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 33585689)

  • 81. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
    Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
    Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort Study.
    Pouwels S; Ramnarain D; Aupers E; Rutjes-Weurding L; van Oers J
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34210077
    [No Abstract]   [Full Text] [Related]  

  • 85. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy.
    Monda VM; Voci C; Strollo F; Passaro A; Greco S; Monesi M; Bigoni R; Porcellati F; Piani D; Satta E; Gentile S
    Diabetes Ther; 2023 Dec; 14(12):2127-2142. PubMed ID: 37801224
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids: A retrospective cohort study.
    Aomar-Millán IF; de Victoria-Carazo JM; Fernández Reyes D; Torres-Parejo Ú; Pérez Fernández L; Martínez-Diz S; Ceballos Torres A; López Gómez J; Bizzarri F; Raya Álvarez E; Salvatierra J
    PLoS One; 2023; 18(3):e0283529. PubMed ID: 36961847
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19.
    Torres-Torres J; Espino-Y-Sosa S; Poon LC; Solis-Paredes JM; Estrada-Gutierrez G; Espejel-Nuñez A; Juarez-Reyes A; Etchegaray-Solana A; Alfonso-Guillen Y; Aguilar-Andrade L; Hernández-Pacheco JA; Villafan-Bernal JR; Martinez-Portilla RJ
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):202-208. PubMed ID: 34664753
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2.
    Grima AA; Murison KR; Simmons AE; Tuite AR; Fisman DN
    Clin Infect Dis; 2023 Feb; 76(3):e409-e415. PubMed ID: 35616115
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparative Effectiveness of Dexamethasone versus Prednisone in Children Hospitalized with Asthma.
    Parikh K; Hall M; Mittal V; Montalbano A; Gold J; Mahant S; Wilson KM; Shah SS
    J Pediatr; 2015 Sep; 167(3):639-44.e1. PubMed ID: 26319919
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.
    Colombi D; Bodini FC; Petrini M; Maffi G; Morelli N; Milanese G; Silva M; Sverzellati N; Michieletti E
    Radiology; 2020 Aug; 296(2):E86-E96. PubMed ID: 32301647
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities.
    Serrano Fernández L; Ruiz Iturriaga LA; España Yandiola PP; Méndez Ocaña R; Pérez Fernández S; Tabernero Huget E; Uranga Echeverria A; Gonzalez Jimenez P; García Hontoria P; Torres Martí A; Menendez Villanueva R; Zalacain Jorge R
    Int J Infect Dis; 2022 Feb; 115():39-47. PubMed ID: 34800689
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study.
    Shionoya Y; Taniguchi T; Kasai H; Sakuma N; Imai S; Shikano K; Takayanagi S; Yahaba M; Nakada TA; Igari H; Sakao S; Suzuki T
    PLoS One; 2021; 16(9):e0256977. PubMed ID: 34473766
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Memel ZN; Lee JJ; Foulkes AS; Chung RT; Thaweethai T; Bloom PP
    J Infect Dis; 2022 Jan; 225(1):19-29. PubMed ID: 34665852
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.
    Di Mascio D; Khalil A; Saccone G; Rizzo G; Buca D; Liberati M; Vecchiet J; Nappi L; Scambia G; Berghella V; D'Antonio F
    Am J Obstet Gynecol MFM; 2020 May; 2(2):100107. PubMed ID: 32292902
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Corticosteroids in critical COVID-19: Are all corticosteroids equal?
    Du Plessis EM; Lalla U; Allwood BW; Louw EH; Nortje A; Parker A; Taljaard JJ; Ayele BT; Nyasulu PS; Koegelenberg CFN
    S Afr Med J; 2021 Apr; 111(6):550-553. PubMed ID: 34382564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.